CanNegev

An Israeli incubator for entrepreneurs and startups in the field of medical cannabis and related technologies.

Incubator Active Yeruham, Israel Est. 2019
Visit website ↗ LinkedIn
Last updated 2026-07-20
Portfolio
6
in our dataset
Rounds participated
7
Rounds led
0
Rounds' value
$1.8M
total disclosed, rounds participated
Stages
Pre-Seed, Seed, A Round

About

CanNegev is an incubator for entrepreneurs and startups focused on medical cannabis innovations in biotech, pharma, agtech, cleantech, and foodtech. Backed by the Israel Innovation Authority (IIA), Padagis Pharmaceuticals Israel, BOL Pharma, and OurCrowd, CanNegev provides financial and professional support, mentoring, and a supportive working environment with medical cannabis laboratories. Its vision is to transform Yeruham and the Negev into a center of knowledge, research, development, and technological innovation for medical cannabis.

Portfolio · 6

3R Pharma
Ophthalmic Cannabis Solutions
2 rounds $800K committed Latest: 2023-02
Ramon Agtech
Autonomous Robot for Diseases and Pests Detection
1 round Latest: 2022-08
Day Three Labs
Pharmaceutical-grade Cannabinoid Infusion Technology
1 round $75K committed Latest: 2021-10
Sol-Del Medical
Medical PVA Soluble Delivery Platform
1 round Latest: 2021-10
RobotPicks
Autonomous Harvester
1 round Latest: 2021-06
Economotor Innovation
Power Control System for Electric Motors
1 round $900K committed

Investment activity

Portfolio by sector

Health Tech & Life Sciences3
Agriculture & Food Technologies2
Energy Tech1

Q&A

What is CanNegev's primary focus as an incubator?
CanNegev is an incubator for entrepreneurs and startups in the field of medical cannabis, focusing on innovations in biotech, pharma, agtech, cleantech, and foodtech related to medical cannabis.
Which organizations back CanNegev?
CanNegev is backed by the Israel Innovation Authority (IIA), Padagis Pharmaceuticals Israel.
What investment stages does CanNegev typically participate in?
CanNegev typically invests in Pre-Seed, Seed, and A Round stages.
Can you name some of CanNegev's portfolio companies?
CanNegev's portfolio includes 3R Pharma, which focuses on Ophthalmic Cannabis Solutions, and Day Three Labs, which develops.
What is CanNegev's most recent disclosed investment?
CanNegev participated in a Seed round for Economotor Innovation in February 2023, which raised $900K.
What is the sector concentration of CanNegev's portfolio?
CanNegev's portfolio shows a concentration in Health Tech & Life Sciences with three companies, and Agriculture & Food Technologies with two companies.
Who are the key executives at CanNegev?
Israel Birenbaum serves as the CEO and Ziv Bet-Or is the VP Business Development at CanNegev.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)